W J Hwu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

W J Hwu

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Investigational New Drugs|May 31, 2014

A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populationsE R Plimack, J R Desai, J P Issa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.

Science (New York, N.Y.)|November 4, 2017

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patientsV Gopalakrishnan, C N Spencer, L Nezi, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Investigational New Drugs|May 31, 2014

A phase I study of decitabine with pegylated interferon α-2b in advanced melanoma: impact on DNA methylation and lymphocyte populationsE R Plimack, J R Desai, J P Issa, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.

Science (New York, N.Y.)|November 4, 2017

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patientsV Gopalakrishnan, C N Spencer, L Nezi, et al.

Pageof 2